HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Citric Acid → (S)-tert-Butyl 2-((S)-2-(6-bromopyridin-3-yl)-1-cyanoethylcarbamoyl)piperidine-1-carboxylate

HRID 600300
Print

Reaction equation

HRID 600300 reaction equation
C1(C(=NC[C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])C2C=CC=CC=2)C=CC=CC=1.[Br-].C(O[C@H](C1C2C(=CC=CC=2)N=CC=1)[C@@H:29]1C[C@@H]2CC[N+:30]1(CC1C3C(C=C4C=1C=CC=C4)=CC=CC=3)C[C@@H]2C=C)C=C.C([N:68]=P1(N(CC)CC)N(C)CCCN1C)(C)(C)C.[Br:82][C:83]1[N:88]=[CH:87][C:86]([CH2:89][C@H:90]([N:98]=C(C2C=CC=CC=2)C2C=CC=CC=2)[C:91](OC(C)(C)C)=O)=[CH:85][CH:84]=1.[C:112](O)(=O)[CH2:113][C:114]([CH2:119][C:120]([OH:122])=O)(C(O)=O)O>C(Cl)Cl.C1COCC1.O>[Br:82][C:83]1[N:88]=[CH:87][C:86]([CH2:89][C@H:90]([NH:98][C:120]([C@@H:119]2[CH2:114][CH2:113][CH2:112][CH2:29][N:30]2[C:16]([O:18][C:19]([CH3:20])([CH3:21])[CH3:22])=[O:17])=[O:122])[C:91]#[N:68])=[CH:85][CH:84]=1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

9

Reactant 5

HCID 311Citric AcidHCID 688171N-(Diphenylmethylene)glycine tert-butyl esterHCID 35138512-((1,1-Dimethylethyl)imino)-N,N-diethylhexahydro-1,3-dimethyl-2lambda5-1,3,2-diazaphosphorin-2-amineHCID 10886583O-Allyl-N-(9-anthracenylmethyl)cinchonidinium bromideHCID 87332171(s)-Tert-butyl 3-(6-bromopyridin-3-yl)-2-(diphenylmethyleneamino)propanoate

Product 1

HCID 57999686(S)-tert-Butyl 2-((S)-2-(6-bromopyridin-3-yl)-1-cyanoethylcarbamoyl)piperidine-1-carboxylate

Reagents, catalysts & solvents 3

HCID 962WaterSolventHCID 6344DichloromethaneSolventHCID 8028TetrahydrofuranSolvent

Conditions

Temperature
-78 °C

Procedure

To a slurry of 2-bromo-5-methylpyridine (10.29 g) and N-bromosuccinimide (5.32 g) in carbon tetrachloride (150 mL) was added AIBN (200 mg) and the reaction vessel was purged with nitrogen. The reaction mixture was heated, under reflux, for 1.5 h then allowed to cool to room temperature. The reaction mixture was filtered and the filtrate was concentrated in vacuo to give 2-bromo-5-(bromomethyl)pyridine (4 g). This, together with tert-butyl 2-(diphenylmethyleneamino)acetate (4.71 g) and (2S,4S,5R)-2-((R)-allyloxy(quinolin-4-yl)methyl)-1-(anthracen-9-ylmethyl)-5-vinyl-1-azoniabicyclo[2.2.2]octane bromide (1.073 g) was dissolved in DCM (100 mL) and the solution was cooled to −78° C. under nitrogen. 2-tert-Butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine (5 mL) was added dropwise over 5 min and the mixture was stirred at −78° C. for 7 h then allowed to reach RT overnight. The reaction mixture was concentrated in vacuo and partitioned between ethyl acetate and water. The ethyl acetate was washed with brine, dried over magnesium sulfate, filtered and concentrated in vacuo. The material obtained, (S)-tert-butyl 3-(6-bromopyridin-3-yl)-2-(diphenylmethyleneamino)propanoate (6 g), was dissolved in THF (75 mL) and to the solution was added citric acid (22 g) in water (75 mL). The mixture was stirred vigorously for 6 h then concentrated in vacuo and loaded onto an SCX cartridge. The cartridge was washed with water then methanol. The product was eluted with 10% ammonia in methanol. The solvent was removed in vacuo to give the sub-title compound (4.0 g).

Workup

  1. waitto reach RT overnight
  2. concentrationThe reaction mixture was concentrated in vacuo
  3. custompartitioned between ethyl acetate and water
  4. washThe ethyl acetate was washed with brine
  5. dry with materialdried over magnesium sulfate
  6. filtrationfiltered
  7. concentrationconcentrated in vacuo
  8. customThe material obtained
  9. stirringThe mixture was stirred vigorously for 6 h
  10. concentrationthen concentrated in vacuo
  11. washThe cartridge was washed with water
  12. washThe product was eluted with 10% ammonia in methanol
  13. customThe solvent was removed in vacuo

Sources & evidence

ORD record
ord-d4b1715be58e4b69a2b96225156dafdb
Source dataset
uspto-grants-2011_03
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07902181B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes